Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes

American Heart Journal

Volumn 140, Issue 6, 2000, Pages 917-927

  Ottani, Filippo ^a   Galvani, Marcello ^a,b   Nicolini, Francesca Antonia ^a   Ferrini, Donatella ^a,b   Pozzati, Andrea ^a   Di Pasquale, Giuseppe ^a   Jaffe, Allan S ^c  

^a Ospedale di Bentivoglio   (Italy)

^b U O Pneumologia G B Morgagni Hospital   (Italy)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE COURSE; ELECTROCARDIOGRAM; FOLLOW UP; HEART DEATH; HEART MUSCLE ISCHEMIA; HUMAN; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; ST SEGMENT; UNSTABLE ANGINA PECTORIS;

EID: 0033669294     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.111107     Document Type: Article

References (52)

1. Acute coronary syndromes in the GUSTO-IIb trial: Prognostic insight and impact of recurrent ischemia
2. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease: The FRISC study group
3. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
4. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3697 patients
5. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction: Analysis of 28 months of follow-up in 196 patients
6. The prognostic value of serum troponin T in unstable angina
7. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
8. Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris
9. Prognostic significance of early raised cardiac troponin I in unstable angina: Contribution to the identification of a high-risk subgroup
10. Prognostic implications of detection of troponin I in patients with unstable angina pectoris
11. Troponin T as a marker of ischemic myocardial injury
12. The prognostic value of serum troponin T in unstable angina
13. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina
14. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease: TRIM Study Group: Thrombin Inhibition in Myocardial ischemia
15. Cardiac troponin T levels for risk stratification in acute myocardial ischemia: GUSTO IIA Investigators
16. Usefulness of positive troponin-T and negative creatine kinase levels in identifying high-risk patients with unstable angina pectoris
17. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris
18. Early identification of cardiac events with serum troponin T in patients with unstable angina
19. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction
20. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina
21. Prognostic value of cardiac troponin T in unstable angina pectoris
22. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes
23. Diagnosing and managing unstable angina: Agency for Health Care Policy and Research
24. Cardiac troponin I and T in unstable angina: Incidence, correlation, kinetics of release and prognostic value
25. Cardiac troponin T and cardiac troponin I: Relative values in short-term risk stratification of patients with acute coronary syndromes: GUSTO-IIa Investigators
26. Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction
27. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban
28. Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction
29. The FRISC experience with troponin T
30. Cardiac troponin I to predict long term outcome in patients with suspected acute coronary syndromes
31. Prognostic value of cardiac troponin I in patients with chest pain
32. Time to positivity of a bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: A TIMI 11A substudy
33. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction
34. Statistical aspects of the analysis of data from retrospective studies of disease
35. Meta-analysis in clinical trials
36. Beta blockade during and after myocardial infarction: An overview of the randomized trials
37. A general estimator for the variance of the Mantel-Haenszel odds ratio
38. Cumulative meta-analysis of therapeutic trials for myocardial infarction
39. A comparison of statistical methods for combining event rates from clinical trials
40. A general parametric approach to the meta-analysis of randomized clinical trials
41. A note on a graphical presentation of estimated odds ratios from several clinical trials
42. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
43. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies
44. Metaanalysis in clinical chemistry: Validation of cardiac troponin T as a marker for ischemic heart diseases
45. Concurrent elevations of cross-linked fibrin degradation products identify high-risk of coronary events in patients with acute coronary syndromes and elevated troponin I
46. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina
47. The role of cardiac troponin T and other new biochemical markers in evaluation and risk stratification of patients with acute chest pain syndromes
48. Angiographic findings in patients with refractory unstable angina according to troponin status
49. Long-term low-molecular-mass heparin in unstable coronary artery disease: FRISC-II prospective randomised multicenter study
50. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection: FRISC Study Group
51. Clinical efficacy of three assays of cardiac troponin I for risk stratification in acute coronary syndromes: A TIMI 11B substudy